Various providers may refer to their programs as “certification,” but each may not represent the same level of achievement. For example, attendance at a continuing nursing education program is a very different level of achievement than preparing for and passing a comprehensive, broad-based certification exam such as an OCN® test.
The inaugural ONS Connections: Advancing Care Through Science Conference, to be held November 16–18 in Phoenix, AZ, brings nurse scientists and advanced-level nurses together to make the connection between research and practice. At this groundbreaking event, an elite group of cancer nursing leaders will share, discuss, and disseminate knowledge to drive evidence-based practice.
With the close of the 37th Annual ONS Congress in New Orleans earlier this month, Julie Painter, RN, MSN, OCN®, became the new chair of the ONS Nominating Committee. Painter has served the Society in many roles, including past Nominating Committee chair, Oncology Nursing Certification Corporation Nominating Committee member, ONS director-at-large, and Congress planning team member and chair.
Patients receiving hematologic stem cell transplantation (HCT) for leukemia, solid tumors, and immunosuppressive diseases typically are treated in cancer institutions initially. However, approximately 100 days after transplant, patients are returned to their primary healthcare teams, and it is important that the oncology nurses on those teams understand the complexity of continued care for HCT recipients.
When Patricia Kelly, DNP, APRN, CNS, AOCN®, presented a genetics session at the ONS 36th Annual Congress in 2011, many questions were raised about colon cancer genetics. This year, at the ONS 37th Annual Congress in New Orleans, LA, Kelly and Bridget LeGrazie, RN, MSN, APN-C, APNG, AOCN®, aimed to answer those questions